As of 2024-12-12, the Relative Valuation of GeneTether Therapeutics Inc (GTTX.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of GeneTether Therapeutics Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-11-28 | -4.47 |
| 2024-11-26 | -4.47 |
| 2024-11-25 | -1.62 |
| 2024-11-22 | -4.06 |
| 2024-11-21 | -4.06 |
| 2024-11-20 | -4.06 |
| 2024-11-19 | -1.02 |
| 2024-11-15 | -1.02 |
| 2024-11-14 | -0.81 |
| 2024-11-08 | -0.81 |
| 2024-11-06 | -0.61 |
| 2024-10-29 | -1.02 |
| 2024-10-28 | -1.02 |
| 2024-10-17 | -1.02 |
| 2024-10-15 | -0.61 |
| 2024-10-11 | -1.02 |
| 2024-10-02 | -0.81 |
| 2024-09-30 | -0.61 |
| 2024-09-25 | -0.81 |
| 2024-09-24 | -1.22 |
| 2024-09-23 | -0.61 |